Back
ESC Premium Access

Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

Session: Drug therapy in congenital heart disease - What are the options and the needs?
Topic: Pharmacotherapy
Speaker: Miss H. Yang (Amsterdam, NL)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Miss Hayang Yang

Academic Medical Centre, Amsterdam (Netherlands (The))
0 follower

4 more presentations in this session

Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?

Speaker: Assistant Professor M. Westhoff-Bleck (Hannover, DE)

Access
Abstract
Slides
Video
Thumbnail

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Speaker: Doctor C. Yan (Beijing, CN)

Access
Abstract
Slides
Video
Thumbnail

Drug therapy in adult congenital heart disease: the burden of polypharmacy

Speaker: Ms O. Woudstra (Amsterdam, NL)

Access
Abstract
Thumbnail

Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation

Speaker: Mr B. Ruijsink (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Drug therapy in congenital heart disease - What are the options and the needs?

Speakers: Miss H. Yang, Assistant Professor M. Westhoff-Bleck, Doctor C. Yan, Ms O. Woudstra, Mr B. Ruijsink
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb